S
ABUS icon

SignatureFD’s Arbutus Biopharma ABUS Stock Holding History

SignatureFD’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.3K Hold
2,556
– – ﹤0.01% 2566
2026
Q1 		$11.5K Hold
2,556
– – ﹤0.01% 2451
2025
Q4 		$12.3K Hold
2,556
– – ﹤0.01% 2334
2025
Q3 		$11.6K Sell
2,556
-462
-15% -$1.7K ﹤0.01% 2352
2025
Q2 		$9.33K Sell
3,018
-142
-4% -$472 ﹤0.01% 2377
2025
Q1 		$11K Buy
3,160
+85
+3% +$283 ﹤0.01% 2318
2024
Q4 		$10.1K Buy
3,075
+57
+2% +$210 ﹤0.01% 2362
2024
Q3 		$11.6K Hold
3,018
– – ﹤0.01% 2275
2024
Q2 		$9.33K Hold
3,018
– – ﹤0.01% 2291
2024
Q1 		$7.79K Hold
3,018
– – ﹤0.01% 2397
2023
Q4 		$7.54K Sell
3,018
-792
-21% -$1.55K ﹤0.01% 2374
2023
Q3 		$7.73K Sell
3,810
-1,461
-28% -$3.06K ﹤0.01% 2335
2023
Q2 		$12.1K Buy
5,271
+4,109
+354% +$10.7K ﹤0.01% 2153
2023
Q1 		$3.52K Hold
1,162
– – ﹤0.01% 2633
2022
Q4 		$2.71K Buy
1,162
+54
+5% +$129 ﹤0.01% 2704
2022
Q3 		$2K Buy
+1,108
New +$2.61K ﹤0.01% 2721

Other funds holding ABUS

LWA
Ledgewood Wealth Advisors Exeter, New Hampshire $188M AUM 18.45% 1-Year Est. Return
WMA
Wealth Management Associates Cherry Hill, New Jersey $362M AUM 33.28% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
PPWP
Premier Path Wealth Partners Madison, New Jersey $870M AUM 30% 1-Year Est. Return
AHL
Abel Hall LLC Baton Rouge, Louisiana $579M AUM 54.21% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
WFA
WMG Financial Advisors Knoxville, Tennessee $265M AUM 26.03% 1-Year Est. Return
PI
PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

SignatureFD's ABUS Position: Q2 2026 in Review

SignatureFD held its Arbutus Biopharma (ABUS) position steady in Q2 2026 at 2,556 shares worth $12.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2566.

SignatureFD first reported a position in ABUS in Q3 2022 and has held it in 16 quarters since. The position peaked at $12.3K in Q4 2025. 16 funds tracked by Wall St. Rank hold ABUS as of Q2 2026.

  • SignatureFD held 2,556 shares of Arbutus Biopharma worth $12.3K as of Q2 2026.
  • SignatureFD left its Arbutus Biopharma share count unchanged in Q2 2026.
  • Arbutus Biopharma made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #2566 holding.
  • SignatureFD first reported a position in Arbutus Biopharma in Q3 2022 and has held it in 16 quarters since.
  • SignatureFD's Arbutus Biopharma position peaked at $12.3K in Q4 2025.
  • 16 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.